EUCTR2015-002985-22-FI进行中（未招募）1 期
Efficacy of Intermittent Tiotropium in Early Childhood Wheezing
Mika J. Mäkelä0 个研究点目标入组 195 人开始时间: 2015年8月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 195
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Children at the age of 6 to 35 months.
- •2. Two to four physician-confirmed episodes of wheeze and/or shortness of breath.
- •3. Parents/legal representatives with sufficient written and spoken skills in Finnish language
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 195
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Birth before 36th week of gestation.
- •2. Suspected/diagnosed chronic parenchymal lung disease or a structural airway defect, or a history of thoracotomy with pulmonary resection.
- •3. A history of congenital or acquired heart disease, including any unstable or life-threatening cardiac arrhythmia.
- •4. Constipation with a need of regular medication, or a diagnosed/suspected structural defect in the gastrointestinal tract.
- •5. A history of malignancy, or other significant chronic disorder, disease, or defect.
研究者
相似试验
已完成
4 期
Efficacy of Intermittent Tiotropium in Early Childhood WheezingWheezy BronchitisWheezingObstruction AirwayAsthmatic BronchitisNCT03199976Helsinki University Central Hospital80
进行中（未招募）
1 期
A PAEDIATRIC PHASE I/II STUDY OF INTERMITTENT DOSING OF THE MEK-1 INHIBITOR SELUMETINIB IN CHILDREN WITH NEUROFIBROMATOSIS TYPE-1 AND INOPERABLE PLEXIFORM NEUROFIBROMA AND/OR PROGRESSIVE OPTIC PATHWAY GLIOMANeurofibromatosis type 1 associated plexiform neurofibromas Neurofibromatosis type 1 associated progressive or relapsed optic pathway gliomaMedDRA version: 20.0 Level: LLT Classification code 10029270 Term: Neurofibromatosis, type 1 (von Recklinghausen's disease) System Organ Class: 100000004850MedDRA version: 20.0 Level: LLT Classification code 10065866 Term: Plexiform neurofibroma System Organ Class: 100000004864MedDRA version: 20.0 Level: LLT Classification code 10030935 Term: Optic nerve glioma System Organ Class: 100000004864EUCTR2017-002635-41-GBGreat Ormond Street Hospital38
已完成
不适用
Comparison of the effect of tiotropium monotherapy versus tiotropium and indacaterol combination therapy in patients with chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease (COPD)JPRN-UMIN000009077Department of Respiratory Medicine, Chiba-Hokusoh Hospital, Nippon Medical School60
招募中
3 期
The effectiveness of Tiotropium bromide in patients with severe asthmaIRCT20181015041353N1Zahedan University of Medical Sciences60
进行中（未招募）
不适用
Pharmacokinetics and dose-ranging of tiotropium inhalation solution delivered from the Respimat inhaler in patients with Chronic Obstructive Pulmonary Disease (COPD)EUCTR2009-016251-21-DKBoehringer Ingelheim (UK) Ltd160